Direkt zum Inhalt
Merck
  • Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature.

Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature.

Reviews of infectious diseases (1986-05-01)
P G Spitzer, S M Hammer, A W Karchmer
ZUSAMMENFASSUNG

A 55-year-old female recipient of an orthotopic liver transplant, who was receiving azathioprine, prednisone and cyclosporin, developed bacteremia due to Listeria monocytogenes. Because of a penicillin allergy, the patient was treated primarIly with trimethoprim-sulfamethoxazole, to which she responded well. The prior literature on use of trimethoprim-sulfamethoxazole in listeria infections is reviewed, and future recommendations are considered. On the basis of the experience described in this case report as well as a review of the literature, trimethoprim-sulfamethoxazole appears to be an effective treatment of listeria infections.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Sulfamethoxazol
USP
Sulfamethoxazol, United States Pharmacopeia (USP) Reference Standard
Supelco
Sulfamethoxazol, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Sulfamethoxazol, VETRANAL®, analytical standard
Sulfamethoxazol, European Pharmacopoeia (EP) Reference Standard
Supelco
Sulfamethoxazol, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland